|

Alpha 1-Antitrypsin Clinical Trials

1 actively recruiting trial

Also known as: Kamada alpha 1-antitrypsin for inhalation

Pipeline

Phase 3: 1

Top Sponsors

  • Kamada, Ltd.1

Indications

  • Alpha 1-Antitrypsin Deficiency1
  • Liver Disease1

Other1 trial

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.